User menu

Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment

Bibliographic reference Kamga, Guy-Roger ; Dissak Delon, Fanny ; Nana-Djeunga, Hugues C ; Biholong, Benjamin D ; Mbigha-Ghogomu, Stephen ; et. al. Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment. In: Parasites & Vectors, Vol. 9, no.581, p. 1-12 (2016)
Permanent URL
  1. Remme JHF, Feenstra P, Lever PR, Medici AC, Morel CM, Noma M, et al. Tropical diseases targeted for elimination: Chagas disease, lymphatic filariasis, onchocerciasis, and leprosy. In: Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington (DC): Oxford University Press and The World Bank; 2006. p. 433–50.
  2. Zouré Honorat GM, Noma Mounkaila, Tekle Afework H, Amazigo Uche V, Diggle Peter J, Giorgi Emanuele, Remme Jan HF, The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected, 10.1186/1756-3305-7-326
  3. Plaisier A.P., van Oortmarssen G.J., Remme J., Habbema J.D.F., The reproductive lifespan of Onchocerca volvulus in West African savanna, 10.1016/0001-706x(91)90015-c
  4. Duke BO. The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol. 1993;44:61–8.
  5. Murdoch Michele E, Onchodermatitis : , 10.1097/qco.0b013e328336a256
  6. Murdoch M. E., Asuzu M. C., Hagan M., Makunde W. H., Ngoumou P., Ogbuagu K. F., Okello D., Ozoh G., Remme J., Onchocerciasis: the clinical and epidemiological burden of skin disease in Africa, 10.1179/000349802125000826
  7. Hoerauf A., Science, medicine, and the future: Onchocerciasis, 10.1136/bmj.326.7382.207
  8. Resnikoff Serge, Keys TriciaU, Future trends in global blindness, 10.4103/0301-4738.100532
  9. Tchounkeu Yolande Flore Longang, Onyeneho Nkechi G., Wanji Samuel, Kabali Asaph Turinde, Manianga Célé, Amazigo Uche V., Amuyunzu-Nyamongo Mary, Changes in stigma and discrimination of onchocerciasis in Africa, 10.1016/j.trstmh.2012.02.009
  10. Evans TG. Socioeconomic consequences of blinding onchocerciasis in west Africa. Bull World Health Organ. 1995;73:495–506.
  11. WHO. The involvement of community-directed distributors of ivermectin in other health and development activities: report of a multi-country study. UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. 2003. p. 1–47.
  12. WHO, Community-directed interventions for major health problems in Africa, ISBN:9789241596602, 10.2471/tdr.08.978-924-1596602
  13. Hopkins Adrian, Boatin Boakye A., Onchocerciasis, Water and Sanitation-Related Diseases and the Environment ISBN:9781118148594 p.133-149, 10.1002/9781118148594.ch11
  14. WHO. African programme for onchocerciasis control: progress report, 2013-2014. Wkly Epidemiol Rec. 2014;89:551–60.
  15. Katabarwa Moses, Richards Frank, Twice-yearly ivermectin for onchocerciasis: the time is now, 10.1016/s1473-3099(14)70732-7
  16. WHO. Progress towards eliminating onchocerciasis in the WHO region of the Americas: verification by WHO of elimination of transmission in Colombia. Wkly Epidemiol Rec. 2013;88:381–5.
  17. WHO. Elimination of onchocerciasis in the WHO region of the Americas: Ecuador's progress towards verification of elimination. Wkly Epidemiol Rec. 2014;89:401–5.
  18. WHO. Progress toward eliminating onchocerciasis in the WHO Region of the Americas: verification of elimination of transmission in Mexico. Wkly Epidemiol Rec. 2015;90:577–81.
  19. CDC. Progress toward elimination of onchocerciasis in the Americas: 1993-2012. MMWR Morb Mortal Wkly Rep. 2013;62:405–8.
  20. Rodríguez-Pérez Mario A., Fernández-Santos Nadia A., Orozco-Algarra María E., Rodríguez-Atanacio José A., Domínguez-Vázquez Alfredo, Rodríguez-Morales Kristel B., Real-Najarro Olga, Prado-Velasco Francisco G., Cupp Eddie W., Richards Frank O., Hassan Hassan K., González-Roldán Jesús F., Kuri-Morales Pablo A., Unnasch Thomas R., Elimination of Onchocerciasis from Mexico, 10.1371/journal.pntd.0003922
  21. WHO. Onchocerciasis: elimination is feasible. Wkly Epidemiol Rec. 2009;84:382–3.
  22. Diawara Lamine, Traoré Mamadou O., Badji Alioune, Bissan Yiriba, Doumbia Konimba, Goita Soula F., Konaté Lassana, Mounkoro Kalifa, Sarr Moussa D., Seck Amadou F., Toé Laurent, Tourée Seyni, Remme Jan H. F., Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal, 10.1371/journal.pntd.0000497
  23. Katabarwa Moses N., Richards Frank O., Baldiagaï Jean, Madi Théodore Kambaba, Nwane Philippe, Yougouda Abdoulaye, Enyong Peter, Andze Gervais Ondobo, Yaya Souleymanou, Eyamba Albert, Seventeen Years of Annual Distribution of Ivermectin Has Not Interrupted Onchocerciasis Transmission in North Region, Cameroon, 10.4269/ajtmh.2011.11-0333
  24. Tekle Afework H., Zouré Honorath G. M., Noma Mounkaila, Boussinesq Michel, Coffeng Luc E., Stolk Wilma A., Remme Jan H. F., Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results, 10.1186/s40249-016-0160-7
  25. WHO. African Programme for Onchocerciasis Control: report of the sixth meeting of national task forces, October 2009. Wkly Epidemiol Rec. 2010;85:23–8.
  26. Nana-Djeunga Hugues C., Bourguinat Catherine, Pion Sébastien D., Bopda Jean, Kengne-Ouafo Jonas A., Njiokou Flobert, Prichard Roger K., Wanji Samuel, Kamgno Joseph, Boussinesq Michel, Reproductive Status of Onchocerca volvulus after Ivermectin Treatment in an Ivermectin-Naïve and a Frequently Treated Population from Cameroon, 10.1371/journal.pntd.0002824
  27. Osei-Atweneboana Mike Y, Eng Jeffrey KL, Boakye Daniel A, Gyapong John O, Prichard Roger K, Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study, 10.1016/s0140-6736(07)60942-8
  28. Pion Sébastien D. S., Nana-Djeunga Hugues C., Kamgno Joseph, Tendongfor Nicholas, Wanji Samuel, Njiokou Flobert, Prichard Roger K., Boussinesq Michel, Dynamics of Onchocerca volvulus Microfilarial Densities after Ivermectin Treatment in an Ivermectin-naïve and a Multiply Treated Population from Cameroon, 10.1371/journal.pntd.0002084
  29. Boussinesq M, Demanga-Ngangue, Richard P, Lele D, Cot S, Chippaux JP. Etude clinique et parasitologique de l’onchocercose dans huit villages de la vallée du Mbam. Bull lias doc OCEAC. 1992; 100:26-31.
  30. Gardon Jacques, Boussinesq Michel, Kamgno Joseph, Gardon-Wendel Nathælie, Demanga-Ngangue, Duke Brian OL, Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial, 10.1016/s0140-6736(02)09456-4
  31. Kamgno Joseph, Gardon Jacques, Gardon-Wendel Nathalie, Demanga-Ngangue, Duke Brian O.L., Boussinesq Michel, Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly, 10.1016/j.trstmh.2003.10.018
  32. GTNO. Rapport technique annuel 2014 du Groupe de Travail National de lutte contre l’Onchocercose du Cameroun. 2015. p. 70.
  33. Albiez EJ. Effects of a single complete nodulectomy on nodule burden and microfilarial density two years later. Trop Med Parasitol. 1985;36:17–20.
  34. Albiez EJ, Buttner DW, Duke BO. Diagnosis and extirpation of nodules in human onchocerciasis. Trop Med Parasitol. 1988;39 Suppl 4:331–46.
  35. Ngoumou P., Walsh J. F., Mace J. M., A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study, 10.1080/00034983.1994.11812893
  36. Prost A, Prod'hon J. Le diagnostic parasitologique de l’onchocercose: revue critique des méthodes en usage. Med Trop. 1978;38:519–32.
  37. BUCREP. Projections démographiques du troisième Recensement Général de la Population et de l’Habitat (3ème RGPH) du Cameroun. 3rd ed. 2010. p. 91.
  38. Prost A, Hervouet JP, Thylefors B. Les niveaux d’endémie de l’onchocercose. Bull World Health Organ. 1979;57:655–62.
  39. Stolk Wilma A., Walker Martin, Coffeng Luc E., Basáñez María-Gloria, de Vlas Sake J., Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis, 10.1186/s13071-015-1159-9
  40. APOC. Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. 2010. p. 24.
  41. Brieger William R, Okeibunor Joseph C, Abiose Adenike O, Wanji Samuel, Elhassan Elizabeth, Ndyomugyenyi Richard, Amazigo Uche V, Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria, 10.1186/1756-3305-4-152
  42. Brieger William R., Okeibunor Joseph C., Abiose Adenike O., Ndyomugyenyi Richard, Kisoka William, Wanji Samuel, Elhassan Elizabeth, Amazigo Uche V., Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control : Compliance to annual ivermectin treatment, 10.1111/j.1365-3156.2006.01796.x
  43. Wanji Samuel, Kengne-Ouafo Jonas A., Esum Mathias E., Chounna Patrick W. N., Adzemye Bridget F., Eyong Joan E. E., Jato Isaac, Datchoua-Poutcheu Fabrice R., Abong Raphael A., Enyong Peter, Taylor David W., Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon, 10.1186/s13071-015-1283-6
  44. Traore Mamadou O., Sarr Moussa D., Badji Alioune, Bissan Yiriba, Diawara Lamine, Doumbia Konimba, Goita Soula F., Konate Lassana, Mounkoro Kalifa, Seck Amadou F., Toe Laurent, Toure Seyni, Remme Jan H. F., Proof-of-Principle of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: Final Results of a Study in Mali and Senegal, 10.1371/journal.pntd.0001825
  45. Tekle Afework, Elhassan Elizabeth, Isiyaku Sunday, Amazigo Uche V, Bush Simon, Noma Mounkaila, Cousens Simon, Abiose Adenike, Remme Jan H, Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control, 10.1186/1756-3305-5-28
  46. Newell ED, Ndimuruvugo N. Endémicité et manifestations cliniques de l’onchocercose dans la province de Rutana, Burundi. Bull Soc Pathol Exot. 1997;90:107–10.
  47. Newell E. D., Hicuburundi B., Ndimuruvugo N., Endemicity and clinical manifestations of onchocerciasis in the province of Bururi, Burundi, 10.1046/j.1365-3156.1997.d01-263.x
  48. Ameh GI, Ukatu VE, Adamu T, Muazu S. Skin microfilariae and clinical manifestations of onchocerciasis in some villages at Kwanji district of Kebbi state, Nigeria. Jos J Med. 2008;3:33–6.
  49. Katabarwa M, Onapa AW, Nakileza B. Rapid epidemiological mapping of onchocerciasis in areas of Uganda where Simulium neavei sl is the vector. East Afr Med J. 1999;76:440–6.